Results 41 to 50 of about 7,805 (301)

Therapeutic Perspectives for the Perioperative Period in Oral Squamous Cell Carcinoma (OSCC)

open access: yesFrontiers in Oral Health, 2022
The perioperative period is the relatively short window of time, usually measured in days or weeks, around the surgical procedure. Despite its short duration, this time period is of great importance for cancer patients.
Antoine Galmiche   +9 more
doaj   +1 more source

The 'top 100' drugs and classes in England An updated 'starter formulary' for trainee prescribers. [PDF]

open access: yes, 2018
AIMS: Prescribing is a complex skill required of doctors and, increasingly, other healthcare professionals. Use of a personal formulary can help to develop this skill. In 2006-9, we developed a core list of the 100 most commonly prescribed drugs. Our aim
Audi, S   +6 more
core   +2 more sources

Anti‐PD‐1 Nanobody‐Armored MSLN CAR‐T Therapy for Malignant Mesothelioma: Preclinical and Clinical Studies

open access: yesAdvanced Science, EarlyView.
A novel therapy using engineered immune cells (NAC‐T cells) showed promise for refractory malignant mesothelioma. Based on the encouraging preclinical data, the first‐in‐human trial is initiated, demonstrating tolerable safety and promising anti‐tumor activity (ORR 63.6%, DCR 100%, including one CR).
Yan Sun   +23 more
wiley   +1 more source

Drug review: Fosaprepitant

open access: yesIndian Journal of Medical and Paediatric Oncology, 2019
Chemotherapy-induced nausea and vomiting (CINV) is a significant contributor to the treatment morbidity experienced by patients with cancer. With effective prophylactic anti-emetics given prior to administration of moderately or highly emetogenic ...
Venkatraman Radhakrishnan
doaj   +1 more source

NEPA, a new fixed combination of netupitant and palonosetron, is a cost-effective intervention for the prevention of chemotherapy-induced nausea and vomiting in the UK [PDF]

open access: yes, 2017
Background: The objective was to evaluate the cost-effectiveness of NEPA, an oral fixed combination netupitant (NETU, 300 mg) and palonosetron (PA, 0.5 mg) compared with aprepitant and palonosetron (APPA) or palonosetron (PA) alone, to prevent ...
Bourhis, Francois   +7 more
core   +3 more sources

Autoimmune Encephalitis in Acute Care—Pathology, Diagnosis, and Management

open access: yesAdvanced Science, EarlyView.
ABSTRACT Autoimmune encephalitis (AE) is characterized by immune‐mediated inflammation of the brain parenchyma, presenting with various neurological syndromes, including but not limited to seizures, altered consciousness, neuropsychiatric symptoms, and movement disorders.
Suneesh Thilak   +9 more
wiley   +1 more source

Gastric Pacing in a Child with Severe Gastroparesis and Review of the Literature

open access: yesProceedings of Singapore Healthcare, 2012
Gastroparesis is a disorder characterised by symptoms of and evidence for gastric retention in the absence of mechanical obstruction. Symptoms include nausea and vomiting, early satiety, postprandial fullness, regurgitation and abdominal pain.
Christina Ong MBBS, FRCPCH   +1 more
doaj   +1 more source

Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis

open access: yesPediatric Rheumatology Online Journal, 2017
Background Methotrexate is the most commonly used disease modifying antirheumatic drug in the treatment of juvenile idiopathic arthritis and can be effective in controlling disease in many patients.
Sonja Falvey   +3 more
doaj   +1 more source

THE ANTI-EMETIC EFFECT OF HALOTHANE

open access: yesBritish Journal of Anaesthesia, 1963
A study was undertaken to evaluate the anti-emetic properties of halothane. One hundred and thirty female patients undergoing diagnostic dilatation and curettage, and cystoscopy, were given a standard premedication of atropine 0.65 mg and pethidine 50 mg.
J L, HAUMANN, P A, FOSTER
openaire   +2 more sources

Home - About - Disclaimer - Privacy